JPRN-UMIN000015627已完成未知
Effectiveness and safety of daclatasvir plus asunaprevir for chronic HCV genotype 1 infection - Effectiveness and safety of daclatasvir plus asunaprevir
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 400
研究概览
简要总结
- Daclatasvir plus asunaprevir for HCV genotype 1b was well tolerated and effective for patients without pre-existent NS5A RAVs or simeprevir failure, irrespective of fibrosis status.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 90years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Decompensated cirrhosis (Child B or C) 2. ALT level of more than five times the upper limit of normal range 3. Severe kidney damage (eGFR<30) 4. Coinfection with HBV or HIV 5. Women with pregnancy or breast feeding 6. Patients using contraindication drugs
研究者
相似试验
已完成
4 期
The Safety and Efficacy of Daclatasvir and Asunaprevir With Chronic HCV Genotype 1b Infection and Chronic Renal FailureHepatitis CNCT02580474Myeong Jun Song21
Unknown
4 期
Efficacy and Safety of Daclatasvir Plus Asunaprevir in Chronic Hepatitis CHepatitis C, ChronicNCT02639585Pusan National University Hospital32
已完成
不适用
Safety and efficacy of Daclatasvir and Asunaprevir combination therapy for hemodialyzed patients with genotype 1 chronic hepatitis C infectiohemodialyzed patients with genotype 1 chronic hepatitis C infectionJPRN-UMIN000024227others130
已完成
不适用
Safety and efficacy of Daclatasvir and Asunaprevir combination therapy for hemodialyzed patients with chronic hepatitis Chemodialyzed patients with chronic hepatitis CJPRN-UMIN000016355Hokkaido University Hospital100
已完成
不适用
Efficacy and safety of daclatasvir and asunaprevir in chronic hepatitis C patients with hemodialysisChronic hepatitis C with hemodialysisJPRN-UMIN000016181shonan kamakura general hospital30